Close Menu

NEW YORK ─  Public Health England researchers are evaluating an Oxford Immunotec test that measures T-cell response to SARS-CoV-2 infection as part of a larger study that aims to also evaluate the potential for coronavirus testing in the home.

On Tuesday, Oxford Immunotec, known best for its tuberculosis tests, announced that it is part of a PHE-sponsored study that involves validating its laboratory-based T-Spot Discovery SARS-CoV-2 test alongside lateral flow immunoassays that are in development.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.